Funder
Novartis Pharmaceuticals Corporation
Texas Neurofibromatosis Foundation
Publisher
Springer Science and Business Media LLC
Reference23 articles.
1. Franz DN, Weiss BD. Molecular therapies for tuberous sclerosis and neurofibromatosis. Curr Neurol Neurosci Rep. 2012;12(3):294–301.
2. Friedman JM. Neurofibromatosis 1. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, et al., editors. GeneReviews®. Seattle (WA): GeneReviews; 1993. https://www.ncbi.nlm.nih.gov/books/NBK1109/. Accessed 24 Apr 2018.
3. Gutmann DH, Ferner RE, Listernick RH, et al. Neurofibromatosis type 1. Nat Rev Dis Primers. 2017;3:17004.
4. Adams L, Marshall L. Neurofibromatosis type 1. Nat Rev Dis Primers. 2017;3:17005.
5. Roth TM, Petty EM, Barald KF. The role of steroid hormones in the NF1 phenotype: focus on pregnancy. Am J Med Genet A. 2008;146A(12):1624–33.
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献